Il y a eu 50 transactions d'initiés récentes enregistrées pour Cytosorbents Corporation (CTSO), dont 37 achats et 12 ventes. Le total des achats d'initiés s'élève à $1.81M et le total des ventes d'initiés à $1.09M.
Les initiés notables ayant une activité récente comprennent Chan Phillip P., Mariani Peter J, Capponi Vincent. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CTSO
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2025-11-18 |
Chan Phillip P. |
Chief Executive Officer |
Attribution de RSU |
100,000 |
$0.64 |
$64K |
1,482,963 |
| 2025-08-08 |
Mariani Peter J |
Chief Financial Officer |
Attribution de RSU |
90,000 |
$1.00 |
$90K |
90,000 |
| 2025-08-08 |
Capponi Vincent |
President and COO |
Attribution de RSU |
111,100 |
$1.00 |
$111.1K |
111,100 |
| 2025-08-08 |
Jones Edward Raymond |
Director |
Attribution de RSU |
22,000 |
$1.00 |
$22K |
22,000 |
| 2025-08-08 |
Chan Phillip P. |
Chief Executive Officer |
Attribution de RSU |
136,400 |
$1.00 |
$136.4K |
136,400 |
| 2025-08-08 |
Sobel Alan D. |
Director |
Attribution de RSU |
22,000 |
$1.00 |
$22K |
22,000 |
| 2025-08-08 |
Bator Michael G. |
Director |
Attribution de RSU |
44,000 |
$1.00 |
$44K |
44,000 |
| 2025-08-08 |
Deliargyris Efthymios |
Chief Medical Officer |
Attribution de RSU |
95,000 |
$1.00 |
$95K |
95,000 |
| 2025-08-08 |
Kim Jiny |
Director |
Attribution de RSU |
22,000 |
$1.00 |
$22K |
22,000 |
| 2025-02-24 |
Mariani Peter J |
Chief Financial Officer |
Exercice d'Options (OTM) |
32,625 |
$1.13 |
$36.87K |
- |
| 2025-02-24 |
Capponi Vincent |
President and COO |
Exercice d'Options (OTM) |
12,000 |
$1.13 |
$13.56K |
- |
| 2025-02-24 |
Chan Phillip P. |
Chief Executive Officer |
Exercice d'Options (OTM) |
34,168 |
$1.13 |
$38.61K |
- |
| 2025-02-24 |
Sobel Alan D. |
Director |
Exercice d'Options (OTM) |
21,950 |
$1.13 |
$24.8K |
- |
| 2025-02-24 |
Bator Michael G. |
Director |
Exercice d'Options (OTM) |
15,879 |
$1.13 |
$17.94K |
- |
| 2025-01-17 |
Mariani Peter J |
Chief Financial Officer |
Exercice d'Options (ITM) |
32,625 |
$1.00 |
$32.63K |
- |
| 2025-01-17 |
Capponi Vincent |
President and COO |
Exercice d'Options (ITM) |
31,760 |
$1.00 |
$31.76K |
- |
| 2025-01-17 |
Chan Phillip P. |
Chief Executive Officer |
Exercice d'Options (ITM) |
90,832 |
$1.00 |
$90.83K |
- |
| 2025-01-17 |
Sobel Alan D. |
Director |
Exercice d'Options (ITM) |
21,950 |
$1.00 |
$21.95K |
- |
| 2025-01-17 |
Bator Michael G. |
Director |
Exercice d'Options (ITM) |
15,879 |
$1.00 |
$15.88K |
- |
| 2025-01-17 |
Deliargyris Efthymios |
Chief Medical Officer |
Exercice d'Options (ITM) |
16,233 |
$1.00 |
$16.23K |
- |
| 2024-12-13 |
Mariani Peter J |
Chief Financial Officer |
Achat Informatif |
20,000 |
$0.96 |
$19.29K |
401,363 |
| 2024-12-12 |
Mariani Peter J |
Chief Financial Officer |
Achat Informatif |
20,000 |
$0.89 |
$17.87K |
381,363 |
| 2024-12-11 |
Mariani Peter J |
Chief Financial Officer |
Achat Informatif |
11,363 |
$0.89 |
$10.1K |
361,363 |
| 2024-10-04 |
Capponi Vincent |
President and COO |
Attribution de RSU |
50,000 |
$1.19 |
$59.5K |
50,000 |
| 2024-10-04 |
Deliargyris Efthymios |
Chief Medical Officer |
Attribution de RSU |
50,000 |
$1.19 |
$59.5K |
50,000 |
| 2024-08-14 |
Mariani Peter J |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-08-14 |
Mariani Peter J |
Chief Financial Officer |
Attribution de RSU |
80,000 |
$0.90 |
$72K |
80,000 |
| 2024-04-02 |
Capponi Vincent |
President and COO |
Attribution de RSU |
101,000 |
$0.96 |
$96.46K |
101,000 |
| 2024-04-02 |
Jones Edward Raymond |
Director |
Attribution de RSU |
22,000 |
$0.96 |
$21.01K |
22,000 |
| 2024-04-02 |
Bloch Kathleen P. |
Chief Financial Officer |
Attribution de RSU |
87,000 |
$0.96 |
$83.09K |
87,000 |
| 2024-04-02 |
Chan Phillip P. |
Chief Executive Officer |
Attribution de RSU |
124,000 |
$0.96 |
$118.42K |
124,000 |
| 2024-04-02 |
Sobel Alan D. |
Director |
Attribution de RSU |
22,000 |
$0.96 |
$21.01K |
22,000 |
| 2024-04-02 |
Bator Michael G. |
Director |
Attribution de RSU |
44,000 |
$0.96 |
$42.02K |
44,000 |
| 2024-04-02 |
Deliargyris Efthymios |
Chief Medical Officer |
Attribution de RSU |
86,000 |
$0.96 |
$82.13K |
86,000 |
| 2024-04-02 |
Kim Jiny |
Director |
Attribution de RSU |
22,000 |
$0.96 |
$21.01K |
22,000 |
| 2024-03-29 |
Capponi Vincent |
President and COO |
Attribution de RSU |
48,923 |
$0.95 |
$46.48K |
48,923 |
| 2024-03-29 |
Bloch Kathleen P. |
Chief Financial Officer |
Attribution de RSU |
49,038 |
$0.95 |
$46.59K |
49,038 |
| 2024-03-29 |
Chan Phillip P. |
Chief Executive Officer |
Attribution de RSU |
129,998 |
$0.95 |
$123.5K |
129,998 |
| 2024-03-29 |
Deliargyris Efthymios |
Chief Medical Officer |
Attribution de RSU |
47,088 |
$0.95 |
$44.73K |
47,088 |
| 2023-12-13 |
Capponi Vincent |
President & COO |
Achat Informatif |
6,578 |
$2.00 |
$13.16K |
6,578 |
| 2023-12-13 |
Jones Edward Raymond |
Director |
Achat Informatif |
2,631 |
$2.00 |
$5.26K |
2,631 |
| 2023-12-13 |
Bloch Kathleen P. |
Chief Financial Officer |
Achat Informatif |
13,157 |
$2.00 |
$26.31K |
13,157 |
| 2023-12-13 |
Chan Phillip P. |
Chief Executive Officer |
Achat Informatif |
26,315 |
$2.00 |
$52.63K |
26,315 |
| 2023-12-13 |
Sobel Alan D. |
Director |
Achat Informatif |
7,894 |
$2.00 |
$15.79K |
7,894 |
| 2023-12-13 |
Bator Michael G. |
Director |
Achat Informatif |
13,157 |
$2.00 |
$26.31K |
13,157 |
| 2023-12-13 |
Deliargyris Efthymios |
Chief Medical Officer |
Achat Informatif |
7,894 |
$2.00 |
$15.79K |
7,894 |
| 2023-12-13 |
Kim Jiny |
Director |
Achat Informatif |
2,631 |
$2.00 |
$5.26K |
2,631 |
| 2023-09-18 |
Bloch Kathleen P. |
Chief Financial Officer |
Attribution de RSU |
30,000 |
$1.98 |
$59.4K |
30,000 |
| 2023-08-07 |
Bator Michael G. |
Director |
Achat Informatif |
1,000 |
$3.20 |
$3.2K |
86,800 |
| 2023-08-07 |
D'amico Alex |
Chief Financial Officer |
Cession |
215,000 |
$3.48 |
$748.2K |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
